{"id":"W2924267060","doi":"10.1080/09546634.2019.1587145","title":"Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Janssen Research and Development; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Adverse effect; Dosing; Interim analysis; Internal medicine; Randomized controlled trial; Dermatology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003491266,0.0006387682,0.0009839085,0.0002009842,0.0002649316,0.0006105586,0.0004947503,0.0007835813,0.002474174],"category_scores_gemma":[0.001387553,0.0002965678,0.001175445,0.0002255628,0.0006208139,0.000743456,0.000202843,0.001806427,0.000422523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004420113,"about_ca_system_score_gemma":0.0007464219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003595179,"about_ca_topic_score_gemma":0.0008099068,"domain_scores_codex":[0.9986646,0.0008225738,0.00007540011,0.0001265465,0.0002135908,0.00009727823],"domain_scores_gemma":[0.9987864,0.00030678,0.0004807501,0.0001033479,0.0000972323,0.0002254899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6597242,0.06539853,0.0140656,0.001721061,0.002284994,0.0001377778,0.0005956613,0.0008536336,0.09469021,0.0002396211,0.002635208,0.1576536],"study_design_scores_gemma":[0.3233022,0.6013467,0.06096993,0.00009260696,0.001251183,0.000500526,0.0001045866,0.001072555,0.008553565,0.0001413605,0.002616405,0.00004844085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958153,0.001958312,0.0004769574,0.000131834,0.00002887708,0.0005998696,0.000297467,0.00003844353,0.0006529208],"genre_scores_gemma":[0.995855,0.001032246,0.0009550419,0.0003855101,0.0000763081,0.0004981461,0.0005057614,0.00001855378,0.0006733451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003491266,"threshold_uncertainty_score":0.01846379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04277174648646291,"score_gpt":0.2797984276950329,"score_spread":0.23702668120857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}